LifeX Ventures

LifeX Ventures is the investment arm of the LifeX Continuum, dedicated to supporting early-stage life sciences startups. Founded in 2022, the firm focuses on bridging the "Valley of Death" for nascent companies in the life sciences field, offering both capital and hands-on guidance. LifeX Ventures combines targeted funding with the expertise necessary to ensure that portfolio companies are scientifically and operationally sound, thus primed for successful market entry.

The firm adopts a structured investment process that prioritizes risk reduction and thorough evaluation. LifeX Ventures typically invests in pre-seed and seed-stage rounds, providing catalytic capital to businesses with validated concepts and clear market fits. The investment strategy includes comprehensive assessments of commercialization roadmaps, regulatory compliance, market potential, and financial structuring. Beyond capital investment, LifeX Ventures emphasizes the provision of strategic insights and ongoing operational support to assist startups in scaling efficiently.

LifeX Ventures specializes in sectors such as medical devices, digital health, healthcare technology, drug discovery tools, biotechnology, pharmaceuticals, and diagnostics. The firm's approach is underscored by a commitment to expedite impactful, scalable solutions in healthcare, utilizing a team of seasoned professionals with significant experience in investment and commercialization.

Managing Partners Dr. Amol Sarva and Dr. Inaki Berenguer lead the venture, bringing a wealth of expertise in both the scientific and entrepreneurial realms. LifeX Ventures maintains a physical presence in Pittsburgh, Pennsylvania and New York, New York, while also having an international footprint that includes Switzerland, Spain, and Singapore.